(CLX) The Clorox - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1890541097
CLX: Cleaning Supplies, Bleach, Laundry Care, Cat Litter, Bags, Wraps
The Clorox Company (NYSE:CLX) is a leading global manufacturer and marketer of consumer and professional products, with a diverse portfolio that spans multiple industries. Founded in 1913 and headquartered in Oakland, California, Clorox operates through four primary segments: Health and Wellness, Household, Lifestyle, and International.
The Health and Wellness segment is a cornerstone of Clorox’s business, offering essential home care products such as cleaning solutions, disinfectants, and bleach under brands like Clorox, Tilex, and Pine-Sol. This segment also includes professional-grade cleaning and disinfecting products under CloroxPro and Clorox Healthcare, catering to institutional and commercial clients. Additionally, it provides food service products under the Hidden Valley brand, highlighting the company’s ability to serve both consumer and professional markets effectively.
The Household segment focuses on everyday consumer goods, including cat litter products under Fresh Step and Scoop Away, food storage solutions from Glad, and grilling products through the Kingsford brand. These brands are household names, reflecting Clorox’s strong market presence in the U.S. consumer goods sector.
The Lifestyle segment diversifies Clorox’s offerings further, featuring condiments, dressings, and sauces under Hidden Valley, water-filtration products through Brita, and natural personal care products via Burt’s Bees. This segment underscores Clorox’s commitment to health-conscious and environmentally conscious consumers, aligning with broader market trends.
The International segment extends Clorox’s reach globally, offering a wide range of products under brands like Glad, Poett, Brita, and Burt’s Bees. This segment highlights the company’s ability to adapt its product portfolio to meet the needs of international markets, ensuring a strong global presence.
Clorox also ventures into vitamins, supplements, and supplements under brands like Natural Vitality, RenewLife, NeoCell, and Rainbow Light, further diversifying its health and wellness offerings. This demonstrates the company’s strategic expansion into growing markets, addressing consumer demand for health and wellness products.
The company’s distribution network is extensive, selling its products through mass retailers, grocery stores, warehouse clubs, dollar stores,
Additional Sources for CLX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLX Stock Overview
Market Cap in USD | 18,272m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1983-03-21 |
CLX Stock Ratings
Growth 5y | 1.78% |
Fundamental | 33.6% |
Dividend | 59.4% |
Rel. Strength Industry | -6.43 |
Analysts | 2.95/5 |
Fair Price Momentum | 150.38 USD |
Fair Price DCF | 130.36 USD |
CLX Dividends
Dividend Yield 12m | 3.18% |
Yield on Cost 5y | 3.36% |
Annual Growth 5y | 2.20% |
Payout Consistency | 93.1% |
CLX Growth Ratios
Growth Correlation 3m | -92% |
Growth Correlation 12m | 64% |
Growth Correlation 5y | -46.9% |
CAGR 5y | 1.67% |
CAGR/Max DD 5y | 0.04 |
Sharpe Ratio 12m | 0.20 |
Alpha | 2.74 |
Beta | -0.04 |
Volatility | 23.73% |
Current Volume | 2376.2k |
Average Volume 20d | 1604.4k |
As of February 22, 2025, the stock is trading at USD 157.25 with a total of 2,376,164 shares traded.
Over the past week, the price has changed by +6.31%, over one month by -0.96%, over three months by -6.32% and over the past year by +6.37%.
Neither. Based on ValueRay Fundamental Analyses, The Clorox is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 33.61 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLX as of February 2025 is 150.38. This means that CLX is currently overvalued and has a potential downside of -4.37%.
The Clorox has received a consensus analysts rating of 2.95. Therefor, it is recommend to hold CLX.
- Strong Buy: 2
- Buy: 0
- Hold: 15
- Sell: 3
- Strong Sell: 1
According to ValueRays Forecast Model, CLX The Clorox will be worth about 162.4 in February 2026. The stock is currently trading at 157.25. This means that the stock has a potential upside of +3.28%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 164.5 | 4.6% |
Analysts Target Price | 164.6 | 4.7% |
ValueRay Target Price | 162.4 | 3.3% |